About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Personalised Program for Women Treated for Hodgkin Disease

NCT01188915·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Institut Paoli-Calmettes

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

women \> 18 years
treated for Hodgkin disease
signed informed consent
high risk of breast cancer

You may not be if

patients unable to have a regular follow-up

The record

StatusTerminated

PhaseNo phase

Taking part51

StartedJul 2010

UpdatedOct 14, 2016

Conditions

Hodgkin Disease Breast Cancer

Where1

François EISINGER, PhD
Marseille, France

Clareo Health | Personalised Program for Women Treated for Hodgkin Disease